HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The role of platelet activating factor and other lipid mediators in inflammatory angiogenesis.

Abstract
Chronic inflammatory diseases are often accompanied by intense angiogenesis. A model of inflammatory angiogenesis is the murine air pouch granuloma which has a hyperangiogenic component. Proinflammatory lipid mediator generation is also a hallmark of chronic inflammation and the role of endogenous production of these mediators in angiogenesis is not known. The 14 kDa phospholipase A2 (PLA2) deacylates phospholipid, liberating arachidonic acid, which is used for leukotriene production, and lysophospholipid, which can drive the production of platelet-activating factor (PAF). Therefore, SB 203347, an inhibitor of the 14 kDa PLA2, zileuton, an inhibitor of 5-lipoxygenase, and Ro 24-4736 a PAF receptor antagonist were evaluated for their effects in the murine air pouch granuloma. SB 203347 reduced both LTB4 and PAF, but not PGD2 levels measured in the day 6 granuloma. This correlated with a significant reduction in angiogenesis. Zileuton reduced LTB4 levels as expected, but did not significantly inhibit angiogenesis, whereas Ro 24-4736 potently reduced angiogenesis. These data support the hypothesis that PAF, and to a lesser extent leukotrienes contribute to the angiogenic phenotype in chronic inflammation.
AuthorsJ R Jackson, B Bolognese, C A Mangar, W C Hubbard, L A Marshall, J D Winkler
JournalBiochimica et biophysica acta (Biochim Biophys Acta) Vol. 1392 Issue 1 Pg. 145-52 (May 20 1998) ISSN: 0006-3002 [Print] Netherlands
PMID9593866 (Publication Type: Journal Article)
CopyrightCopyright 1998 Elsevier Science B. V.
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Inflammation Mediators
  • Leukotrienes
  • Phenanthridines
  • Platelet Activating Factor
  • SB 203347
  • Sulfonamides
  • Triazines
  • Ro 24-4736
  • Phospholipases A
  • Phospholipases A2
  • zileuton
  • Hydroxyurea
Topics
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal (pharmacology)
  • Female
  • Granuloma (metabolism, pathology)
  • Hydroxyurea (analogs & derivatives, pharmacology)
  • Inflammation Mediators (metabolism)
  • Leukotrienes (metabolism)
  • Mice
  • Mice, Inbred BALB C
  • Neovascularization, Pathologic
  • Phenanthridines (pharmacology)
  • Phospholipases A (antagonists & inhibitors)
  • Phospholipases A2
  • Platelet Activating Factor (antagonists & inhibitors, metabolism)
  • Sulfonamides (pharmacology)
  • Triazines (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: